ANXA2 and hepatocellular carcinoma: Sobolewski et al36 reported that S100A11/ANXA2 belongs to a tumor oncogene/tumor suppressor gene network, which can be deregulated through steatosis at an early stage, thereby participating in the development of inflammation and HCC.